Breaking News Instant updates and real-time market news.

NCR

NCR Corp.

$23.83

0.01 (0.04%)

16:28
10/30/18
10/30
16:28
10/30/18
16:28

NCR Corp. backs FY18 EPS view of $2.55-$2.75, consensus $2.60

Backs FY18 revenue growth view of (3%) to (1%). Non-GAAP diluted earnings per share guidance assumes an effective tax rate of 21% for 2018 compared to 25% in 2017.

  • 30

    Oct

  • 29

    Nov

NCR NCR Corp.
$23.83

0.01 (0.04%)

10/23/18
BNCH
10/23/18
NO CHANGE
BNCH
Buy
NCR Corp. deal for JetPay 'seems reasonable,' says Benchmark
Benchmark analyst Daniel Kurnos believes NCR's (NCR) agreement to acquire payment processor JetPay (JTPY) "seems reasonable," noting that the price is relatively in line to somewhat cheaper than similar acquisitions in the payments processing space and the deal will give NCR an end-to-end processing solution that can be offered/bundled with their POS platform. The analyst, who views the deal as a positive indicator of new management's strategy and suspects it was likely achieved because of their connections, keeps a Buy rating on NCR shares.
10/22/18
10/22/18
DOWNGRADE

Underperform
JetPay downgraded to Underperform after NCR takeover announcement at Barrington
As previously reported, Barrington analyst Gary Prestopino downgraded JetPay (JTPY) to Underperform from Outperform based on the pending deal to be acquired by NCR Corp. (NCR) for $5.05 per share and the move in JetPay shares to $4.97 from a close of $2.05 on October 19.
09/20/18
JPMS
09/20/18
NO CHANGE
Target $39
JPMS
Overweight
JPMorgan likes setup for Jabil shares into Q4 results
JPMorgan analyst Paul Coster believes the setup for shares of Jabil (JBL) "looks good" into the company's fiscal Q4 results on September 25. The analyst expects Jabil to post "solid results and issue "constructive" fiscal Q1 guidance given a backdrop of strong IT spending, ramping volumes at NCR (NCR), a new product cycle at GoPro (GPRO) and potentially higher year-over-year margins relating to the seasonal Apple (AAPL) business. The stock will "re-rate" exiting the Q2 print and heading into the new fiscal year, Coster tells investors in a pre-earnings research note. He keeps an Overweight rating on Jabil shares with a $39 price target.
07/27/18
OPCO
07/27/18
DOWNGRADE
OPCO
Perform
NCR Corp. downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Ian Zaffino downgraded NCR Corp to Perform from Outperform, telling investors in a research note that he is moving to the sidelines following the company's "mixed" Q2 results and "much weaker" outlook. Challenges for the company include product line-up, supply chain constraints, pricing pressure, unfavorable mix and higher costs necessary to address supply-chain issues, Zaffino says.

TODAY'S FREE FLY STORIES

ONCE

Spark Therapeutics

$104.41

-0.41 (-0.39%)

07:43
09/18/19
09/18
07:43
09/18/19
07:43
Hot Stocks
Spark Therapeutics, paralympic skier partner for genetic testing awareness »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLAC

KLA-Tencor

$152.55

1.38 (0.91%)

07:42
09/18/19
09/18
07:42
09/18/19
07:42
Recommendations
KLA-Tencor analyst commentary  »

KLA-Tencor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$1.73

-0.045 (-2.54%)

07:40
09/18/19
09/18
07:40
09/18/19
07:40
Hot Stocks
vTv Therapeutics presents additional data from Phase 2 Simplici-T1 study »

vTv Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

07:40
09/18/19
09/18
07:40
09/18/19
07:40
General news
Treasury Market Outlook: yields extended declines overnight »

Treasury Market Outlook:…

GSK

GlaxoSmithKline

$41.10

0.49 (1.21%)

07:38
09/18/19
09/18
07:38
09/18/19
07:38
Conference/Events
FDA Non-Prescription Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

OPGN

OpGen

$7.02

-0.07 (-0.99%)

07:37
09/18/19
09/18
07:37
09/18/19
07:37
Hot Stocks
OpGen says Curetis collaborator obtains option to license ARESdb »

OpGen reported an update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$438.98

3.12 (0.72%)

, TROW

T. Rowe Price

$117.98

1.1 (0.94%)

07:37
09/18/19
09/18
07:37
09/18/19
07:37
Recommendations
BlackRock, T. Rowe Price analyst commentary  »

BlackRock's…

BLK

BlackRock

$438.98

3.12 (0.72%)

TROW

T. Rowe Price

$117.98

1.1 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 27

    Oct

AXDX

Accelerate Diagnostics

$21.30

1.85 (9.51%)

07:36
09/18/19
09/18
07:36
09/18/19
07:36
Hot Stocks
Accelerate Diagnostics reports 'positive' results in three Pheno system studies »

Accelerate Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ADBE

Adobe

$284.59

1.54 (0.54%)

, WWE

WWE

$75.88

1.73 (2.33%)

07:35
09/18/19
09/18
07:35
09/18/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

ADBE

Adobe

$284.59

1.54 (0.54%)

WWE

WWE

$75.88

1.73 (2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

BIIB

Biogen

$238.65

2.54 (1.08%)

07:34
09/18/19
09/18
07:34
09/18/19
07:34
Hot Stocks
Biogen to present new data from SHINE study on safety and efficacy of SPINRAZA »

Biogen announced updates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

IAC

IAC

$236.73

7.5 (3.27%)

, MTCH

Match Group

$79.70

3 (3.91%)

07:33
09/18/19
09/18
07:33
09/18/19
07:33
Recommendations
IAC, Match Group, Angi Homeservices analyst commentary  »

IAC spinoffs could unlock…

IAC

IAC

$236.73

7.5 (3.27%)

MTCH

Match Group

$79.70

3 (3.91%)

ANGI

Angi Homeservices

$7.60

-0.31 (-3.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

EFX

Equifax

$141.79

1.78 (1.27%)

07:32
09/18/19
09/18
07:32
09/18/19
07:32
Hot Stocks
Equifax partners with Urjanet for utility payment data sharing platform »

Equifax and Urjanet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 13

    Nov

BHVN

Biohaven Pharmaceutical

$47.24

-0.8 (-1.67%)

07:32
09/18/19
09/18
07:32
09/18/19
07:32
Hot Stocks
Biohaven Pharmaceutical's verdiperstat selected for ALS platform trial »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$238.65

2.54 (1.08%)

07:32
09/18/19
09/18
07:32
09/18/19
07:32
Hot Stocks
Biogen to initiate DEVOTE clinical trial evaluating higher dose of SPINRAZA »

Biogen announced updates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FDX

FedEx

$173.53

-0.14 (-0.08%)

, UPS

UPS

$122.40

-0.245 (-0.20%)

07:30
09/18/19
09/18
07:30
09/18/19
07:30
Recommendations
FedEx, UPS analyst commentary  »

Hard to see rebound for…

FDX

FedEx

$173.53

-0.14 (-0.08%)

UPS

UPS

$122.40

-0.245 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

  • 17

    Dec

MAS

Masco

$41.28

-1.44 (-3.37%)

07:29
09/18/19
09/18
07:29
09/18/19
07:29
Downgrade
Masco rating change  »

Masco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

07:24
09/18/19
09/18
07:24
09/18/19
07:24
Conference/Events
Tandem Diabetes management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ADBE

Adobe

$284.59

1.54 (0.54%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Recommendations
Adobe analyst commentary  »

Adobe weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

GLW

Corning

$28.25

-1.79 (-5.96%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Recommendations
Corning analyst commentary  »

Corning shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNH

Syneos Health

$54.63

-0.77 (-1.39%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Conference/Events
Syneos Health management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 27

    Sep

AXSM

Axsome Therapeutics

$28.17

-0.97 (-3.33%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Initiation
Axsome Therapeutics initiated  »

William Blair starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$173.53

-0.14 (-0.08%)

07:21
09/18/19
09/18
07:21
09/18/19
07:21
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

  • 17

    Dec

SU

Suncor

$32.14

-0.31 (-0.96%)

07:21
09/18/19
09/18
07:21
09/18/19
07:21
Conference/Events
Suncor management to meet with Morgan Stanley »

Refinery Tour with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

NERV

Minerva

$8.09

-0.03 (-0.37%)

07:20
09/18/19
09/18
07:20
09/18/19
07:20
Initiation
Minerva initiated  »

Minerva initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$138.86

1.25 (0.91%)

07:20
09/18/19
09/18
07:20
09/18/19
07:20
Upgrade
Zimmer Biomet rating change  »

Zimmer Biomet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.